2019
DOI: 10.1016/s1569-9056(19)32751-4
|View full text |Cite
|
Sign up to set email alerts
|

Time to move on: The impending need for a new disease-specific comorbidity index for bladder cancer patients undergoing robot-assisted radical cystectomy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Patients admitted to hospital had statistically significantly higher Charlson Index Scores than AC@H patients, which may suggest that these patients had more complex comorbidities. It is acknowledged though that the Charlson Index has not been recalculated to reflect the advances in medical treatments since its inception in 1993 (Lambert et al, 2019; Quan et al, 2011). Consequently, there is a possibility that the 1‐year mortality rate estimated by the Charlson Index may not be as high as predicted.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Patients admitted to hospital had statistically significantly higher Charlson Index Scores than AC@H patients, which may suggest that these patients had more complex comorbidities. It is acknowledged though that the Charlson Index has not been recalculated to reflect the advances in medical treatments since its inception in 1993 (Lambert et al, 2019; Quan et al, 2011). Consequently, there is a possibility that the 1‐year mortality rate estimated by the Charlson Index may not be as high as predicted.…”
Section: Discussionmentioning
confidence: 99%
“…Not only is an increased Charlson Comorbidity Index associated with a high incidence of mortality, it is also a predictor of future healthcare costs, hospitalisation rates, hospital readmissions and healthcare burden (Austin et al, 2015). The key limitation of the Charlson Comorbidity Index is that it has not been appropriately weighted to reflect advances in medical treatments since its validation in 1993 (Lambert et al, 2019; Neuhaus et al, 2013; Quan et al, 2011). Consequently, Quan et al (2011) updated Charlson Index Score could provide a more reliable score; however, it has not been validated in the UK.…”
Section: Methodsmentioning
confidence: 99%